Animal Models for Pseudomonas aeruginosa Quorum Sensing Studies.
暂无分享,去创建一个
[1] E. Denamur,et al. Bacteriophage LM33_P1, a fast-acting weapon against the pandemic ST131-O25b:H4 Escherichia coli clonal complex. , 2016, The Journal of antimicrobial chemotherapy.
[2] L. Rahme,et al. A Quorum Sensing Signal Promotes Host Tolerance Training Through HDAC1-Mediated Epigenetic Reprogramming , 2016, Nature Microbiology.
[3] L. Rahme,et al. Considerations and caveats in anti-virulence drug development. , 2016, Current opinion in microbiology.
[4] L. Rahme,et al. Evidence for Direct Control of Virulence and Defense Gene Circuits by the Pseudomonas aeruginosa Quorum Sensing Regulator, MvfR , 2016, Scientific Reports.
[5] R. Hartmann,et al. Novel Strategies for the Treatment of Pseudomonas aeruginosa Infections. , 2016, Journal of medicinal chemistry.
[6] R. Gamelli,et al. Burn Injury Alters the Intestinal Microbiome and Increases Gut Permeability and Bacterial Translocation , 2015, PloS one.
[7] A. Tzika,et al. Identification of Anti-virulence Compounds That Disrupt Quorum-Sensing Regulated Acute and Persistent Pathogenicity , 2014, PLoS pathogens.
[8] P. Dziewulski,et al. Gram Negative Wound Infection in Hospitalised Adult Burn Patients-Systematic Review and Metanalysis- , 2014, PloS one.
[9] J. Wilhelmy,et al. A Quorum Sensing Small Volatile Molecule Promotes Antibiotic Tolerance in Bacteria , 2013, PloS one.
[10] W. Quax,et al. Choosing an Appropriate Infection Model to Study Quorum Sensing Inhibition in Pseudomonas Infections , 2013, International journal of molecular sciences.
[11] Wangxue Chen,et al. A Mouse Model of Acinetobacter baumannii-Associated Pneumonia Using a Clinically Isolated Hypervirulent Strain , 2013, Antimicrobial Agents and Chemotherapy.
[12] Robert E W Hancock,et al. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. , 2013, Pathogens and disease.
[13] R. Tompkins,et al. The Quorum Sensing Volatile Molecule 2-Amino Acetophenon Modulates Host Immune Responses in a Manner that Promotes Life with Unwanted Guests , 2012, PLoS pathogens.
[14] Y. Coban,et al. Infection control in severely burned patients. , 2012, World journal of critical care medicine.
[15] M. Corrigan,et al. The role of topical antibiotics used as prophylaxis in surgical site infection prevention. , 2011, The Journal of antimicrobial chemotherapy.
[16] S. Diggle,et al. Quinolones: from antibiotics to autoinducers , 2010, FEMS microbiology reviews.
[17] Alexis Criscuolo,et al. Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections. , 2010, The Journal of infectious diseases.
[18] K. Kerr,et al. Pseudomonas aeruginosa: a formidable and ever-present adversary. , 2009, The Journal of hospital infection.
[19] Nancy D. Hanson,et al. Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms , 2009, Clinical Microbiology Reviews.
[20] K. Hirota,et al. The role of rpoS gene and quorum-sensing system in ofloxacin tolerance in Pseudomonas aeruginosa. , 2009, FEMS microbiology letters.
[21] M. Schuster,et al. Global position analysis of the Pseudomonas aeruginosa quorum‐sensing transcription factor LasR , 2009, Molecular microbiology.
[22] S. Percival,et al. Biofilms in wounds: management strategies. , 2008, Journal of wound care.
[23] I. Kukavica-Ibrulj,et al. Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies , 2008, Laboratory animals.
[24] R. Tompkins,et al. Inhibitors of Pathogen Intercellular Signals as Selective Anti-Infective Compounds , 2007, PLoS pathogens.
[25] C. Murray. Infections in burns. , 2007, The Journal of trauma.
[26] K. Krogfelt,et al. Multiple bacterial species reside in chronic wounds: a longitudinal study , 2006, International wound journal.
[27] D. Church,et al. Burn Wound Infections , 2006, Clinical Microbiology Reviews.
[28] V. Venturi. Regulation of quorum sensing in Pseudomonas. , 2006, FEMS microbiology reviews.
[29] L. Herwaldt,et al. Prospective Analysis of Nosocomial Infection Rates, Antibiotic Use, and Patterns of Resistance in a Burn Population , 2006, Journal of burn care & research : official publication of the American Burn Association.
[30] M. Schluchter,et al. Response to acute lung infection with mucoid Pseudomonas aeruginosa in cystic fibrosis mice. , 2006, American journal of respiratory and critical care medicine.
[31] Eric Déziel,et al. The contribution of MvfR to Pseudomonas aeruginosa pathogenesis and quorum sensing circuitry regulation: multiple quorum sensing‐regulated genes are modulated without affecting lasRI, rhlRI or the production of N‐acyl‐ l‐homoserine lactones , 2004, Molecular microbiology.
[32] C. Goodwin,et al. Burn Wound Infections: Current Status , 1998, World Journal of Surgery.
[33] R. Wunderink,et al. Ventilator-associated pneumonia due to Pseudomonas aeruginosa. , 1996, Chest.
[34] A. Prince,et al. Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection , 1996, Infection and immunity.
[35] C. Ryan,et al. A quantitative model of invasive Pseudomonas infection in burn injury. , 1994, The Journal of burn care & rehabilitation.
[36] H. Polk,et al. Combined topical and systemic antibiotic prophylaxis in experimental wound infection. , 1984, American journal of surgery.
[37] B. Lipovy,et al. Prevalence and resistance of Pseudomonas aeruginosa in severely burned patients: a 10-year retrospective study. , 2010, Acta chirurgiae plasticae.
[38] J. Saffle,et al. Systemic Candida infection in burn patients: a case-control study of management patterns and outcomes. , 2002, Surgical infections.